EPO Patent Publication EP4048683A2: Variant Alpha-Amylases
Summary
The European Patent Office has published patent application EP4048683A2 concerning variant maltopentaose/maltohexaose-forming alpha-amylases, with Danisco US Inc. listed as the applicant. This publication is part of the EPO's regular bulletin for the C07K classification, related to peptides.
What changed
The European Patent Office (EPO) has published patent application EP4048683A2, titled 'Variant maltopentaose/maltohexaose-forming alpha-amylases'. The application was filed by Danisco US Inc. and lists several inventors. This publication is part of the EPO's bulletin for the C07K classification, which pertains to peptides.
This is a patent publication, not a regulatory rule or enforcement action. It does not impose new compliance obligations or deadlines on regulated entities. Companies operating in the biotechnology or pharmaceutical sectors may wish to review the patent details for competitive intelligence or potential licensing opportunities. The designated states indicate broad European coverage for this patent application.
Source document (simplified)
VARIANT MALTOPENTAOSE/MALTOHEXAOSE-FORMING ALPHA-AMYLASES
Publication EP4048683A2 Kind: A2 Mar 11, 2026
Applicants
Danisco US Inc
Inventors
BHATE, Manasi, CHAN, Hon Kit, LASSILA, Jonathan, PAUL, Brian James, RAMER, Sandra W., TRAN, Patricia
IPC Classifications
C07K 14/415 20060101AFI20210430BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.